Produkty 21082-33-7

CAS 21082-33-7 występuje w naszej ofercie pod nazwami: Orcinol glucoside, Orcinol glucoside/ 97.68% (existing batch purity), Orcinol glucoside, Sakakin, Orcinol glucoside 98%. Oferty producentów: GLPBio, TargetMol, Biosynth, TCI, Ambeed. Dostępne opakowania: 10mg, 20mg, 5mg, 2mg, 50mg, 25mg, 1mg, 100mg.

Orcinol glucoside
GLPBio
  • opakowanie: 10mg, 20mg, 5mg
  • Warianty: 3
od 625,12
Zobacz produkt
Orcinol glucoside/ 97.68% (existing batch purity)
TargetMol
  • opakowanie: 20mg
  • Warianty: 1
od 578,44
Zobacz produkt
Orcinol glucoside
Biosynth
  • opakowanie: 2mg, 5mg, 10mg, 25mg
  • Warianty: 5
Zobacz produkt
Sakakin
TCI
  • opakowanie: 10mg, 50mg
  • Warianty: 2
od 177,35
Zobacz produkt
Orcinol glucoside 98%
Ambeed
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 6
od 142,31
Zobacz produkt
Sakakin, 98%, 98%
Chemat
  • opakowanie: 25mg
  • Warianty: 1
od 285,20
Zobacz produkt
Orcinol glucoside, 99.57%
MedChemExpress
  • opakowanie: 1 mg, 5 mg, 10 mg, 10mM/1mL
  • Warianty: 5
od 231,46
Zobacz produkt
Orcinol glucoside (Standard)
MedChemExpress
  • opakowanie: 10 mg, 50 mg, 25 mg, 100 mg
  • Warianty: 5
od 719,08
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(3-hydroxy-5-methylphenoxy)oxane-3,4,5-triol (CAS 21082-33-7) to związek chemiczny o wzorze sumarycznym C13H18O7 i masie molowej 286.28 g/mol. Nazwa systematyczna IUPAC: (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(3-hydroxy-5-methylphenoxy)oxane-3,4,5-triol. InChIKey: YTXIGTCAQNODGD-UJPOAAIJSA-N.

Dane identyfikacyjne
Wzór sumarycznyC13H18O7
Masa molowa286.28 g/mol
Nazwa IUPAC(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(3-hydroxy-5-methylphenoxy)oxane-3,4,5-triol
InChIKeyYTXIGTCAQNODGD-UJPOAAIJSA-N
SMILESCC1=CC(=CC(=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Orcinol glucoside, ORCINOLGLUCOSIDE, beta-D-Glucopyranoside, 3-hydroxy-5-methylphenyl, orcinol-beta-d-glucoside, Orcinol glucoside (Standard), orb1222518, orcinol-O-beta-d-glucopyranoside, orcinol-3-o-beta-glucopyranoside, Sakakin, >=95% (LC/MS-ELSD), |A-D-Glucopyranoside, 3-hydroxy-5-methylphenyl
Izomery (ten sam wzór sumaryczny)
(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-(4-methoxyphenoxy)oxane-3,4,5-triol C13H18O7
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-(hydroxymethyl)phenoxy]oxane-3,4,5-triol C13H18O7
(2R,3S,4S,5S,6R)-2-(hydroxymethyl)-6-(4-methoxyphenoxy)oxane-3,4,5-triol C13H18O7
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-methoxyphenoxy)oxane-3,4,5-triol C13H18O7
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[4-(hydroxymethyl)phenoxy]oxane-3,4,5-triol C13H18O7
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)phenoxy]oxane-3,4,5-triol C13H18O7
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(2-methoxyphenoxy)oxane-3,4,5-triol C13H18O7
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[2-(trideuteriomethoxy)phenoxy]oxane-3,4,5-triol C13H18O7
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxy-2-methylphenoxy)oxane-3,4,5-triol C13H18O7
2-(hydroxymethyl)-6-(4-hydroxy-3-methylphenoxy)oxane-3,4,5-triol C13H18O7